Published 21 hours ago • loading... • Updated 9 hours ago

Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing

Pulnovo Medical has announced the closing of nearly $100 million in Series C financing.
This financing round was co-led by Qiming Venture Partners and Lilly Asia Ventures and was oversubscribed by two times.
The financing will support Pulnovo Medical's global clinical trials and expansion, particularly for the PADN technology, an innovative treatment for pulmonary hypertension.
William Hu at Qiming highlighted confidence in Pulnovo Medical's potential and its groundbreaking advancements in interventional treatments for pulmonary hypertension and chronic heart failure.

Insights by Ground AI

Does this summary seem wrong?

35 Articles

All

Left

Center

Right

Charleston Gazette-Mail

+32 Reposted by 32 other sources

Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing

SHANGHAI, March 2, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This round was co-led by Qiming…

21 hours ago·Charleston, United States

Read Full Article

Cardiovascular News

Pulnovo Medical closes series C financing round in support of two US FDA trials

Pulnovo Medical has announced the closing of nearly US$100 million series C financing. The round was co-led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capital participating on a super pro-rata basis. The proceeds will be used to advance Pulnovo Medical’s global clinical trials, international business expansion and strategic initiatives. The financing round was oversubscrib…

9 hours ago

Read Full Article

FinSMEs

Pulnovo Medical Closes $100M Series C

Pulnovo Medical, a Shanghai, China-based medtech company developing devices for pulmonary hypertension (PH) and heart failure (HF), raised $100M in Series C funding. The round was led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capita. The company intends to use the funds to advance its global […] The post Pulnovo Medical Closes $100M Series C appeared first on FinSMEs.

12 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year